Menopause Effects on Vascular Function

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

July 1, 2016

Primary Completion Date

April 30, 2022

Study Completion Date

November 1, 2022

Conditions
Cardiovascular Risk Factor
Interventions
OTHER

No to Low Endogenous Estrogen

Ganirelix acetate (Antagon) will be used to prevent endogenous production of ovarian hormones in young women. Ganirelix is derived from native GnRH, and acts by competitively blocking GnRH receptors on the pituitary and subsequent pathways. Thus, administration of the GnRH antagonist (GnRHant) suppresses steroidogenesis, leading to low or undetectable serum estrogen and progesterone concentrations, which occurs within two days of initiation of administration (Oberye, Mannaerts, Huisman \& Timmer, 1999; Oberye, Mannaerts, Kleijn, \& Timmer, 1999).

OTHER

Estradiol

Short term estradiol administration elicits changes in vascular function in women, and 0.1mg/day patch is the upper recommended limit for hormone therapy in women (Wenner, Taylor, \& Stachenfeld, 2011; Moreau, Hildreth, Meditz, Deane \& Kohrt, 2012).

Trial Locations (1)

19716

University of Delaware, Newark

All Listed Sponsors
collaborator

American Heart Association

OTHER

lead

University of Delaware

OTHER

NCT03236545 - Menopause Effects on Vascular Function | Biotech Hunter | Biotech Hunter